Project Governance
The governance model for this second stage of the project provides a structure offering a blend of communication and support – incorporating the interconnectivity to CAP and others to support long term development and expansion of the pathology reporting protocols.
To see the governance model – click here.
There are 5 critical elements to the governance model:
1. National Stakeholders
Incorporating:
- Round Table participants – 2007 and 2009
- Round Table Working Party members from the first stage of the project
- Other stakeholders such as those on the notifications list
- College fellows
The key purpose in the creation of the National Stakeholder list is to ensure maximum coverage for information and feedback and to maintain an up-to-date contact list to target the correct people.
2. CanSAC
In Phase 2 of the project the Cancer Services Advisory Committee (CanSAC) is being expanded and restructured to include chairs from all previous expert committees which will enable it to take a larger role in the strategic direction of the project and provide the link to international involvement. It will provide leadership in the development, dissemination and preservation of a national structure for useable, evidence-based cancer pathology reporting standards and guidelines.
3. Project Group
The Project Group has been expanded to incorporate more clinical involvement while maintaining the existing experienced participants from the first project.
Membership
- Assoc. Prof David Ellis, Anatomical Pathologist, RCPA (CHAIR)
- Dr Debra Graves, CEO, Royal College of Pathologists Australasia
- Dr Claire Cooke-Yarborough, Cancer Institute NSW
- Dr Sian Hicks, Project Manger, Colorectal Cancer Research Consortium
- Dr Michael Legg, President, Health Informatics Society Australia
- Assoc. Prof Paul McKenzie, President RCPA
- Dr Cleola Anderiesz, Cancer Australia
- Dr David Roder, Cancer Australia
- Prof Jane Dahlstrom, chair CanSAC
- Ms Meagan Judge, Project Manager, Structured Pathology Reporting of Cancer Project
The project group meets on a 4-6 week basis via teleconference to:
- To monitor project progress
- To review risks and issues
- To provide advice and direction to resolve issues
A subset of this group comprising David Ellis and Debra Graves form the executive committee, who are empowered to make decisions relating to the project on a day to day basis.
4. International interconnectivity
Interconnectivity to international bodies such as CAP and RCPath via the CanSAC membership are an integral part of the new structure.
5. Cancer Specific Expert groups
The expert groups have been restructured into groupings to assist in the alignment with other international bodies to facilitate communication and participation. The expert groups now reflect clinical groupings such as Gastrointestinal rather than Colorectal. The existing chairs from the first project have been maintained and additional chairs asked to fill in the remaining cancer specific groupings. These chairs then form one or more ‘authorship’ groups who will be responsible for the development of the cancer protocols
Chairs will be represented on CanSAC forming a core of experienced protocol developers and they will also be asked to represent the project on international committees such as the CAP cancer protocol development committees.
^ back to Top